Senior Director / Director, Global Medical Affairs (Evidence Generation)

Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.

As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.

Summary of Position:

The Senior Director / Director, Global Medical Affairs (Evidence Generation), reporting to the VP, Global Medical Affairs, will lead the development and execution of the global evidence generation strategy to support market access, reimbursement, value demonstration, and scientific communication for commercial and pipeline products within the Scholar Rock portfolio.

This individual will serve as the global subject matter expert for evidence generation, responsible for identifying evidence gaps, establishing integrated evidence generation plans, and ensuring the successful execution and dissemination of evidence that demonstrates the clinical, economic, and patient-centered value of Scholar Rock therapies. The role requires strong strategic leadership and cross-functional collaboration with Medical Affairs, Clinical Development, Market Access, Commercial, HEOR, and regional teams to optimize product differentiation and support access for patients worldwide.

The successful candidate will partner closely with global and regional stakeholders to generate evidence that informs healthcare decision-making among healthcare professionals, payers, health technology assessment (HTA) bodies, health systems, advocacy organizations, and other key stakeholders.